[1]
Asok Kumar, A. et al. 2025. Assessment of Cytomorphological Features and Risk of Malignancy of Bethesda Category III in Thyroid Cytopathology. Journal of Pathology of Nepal. 15, 1 (Oct. 2025), 2314–2319. DOI:https://doi.org/10.3126/jpn.v15i1.81765.